Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition
Post-acute neurological sequelae of COVID-19 affect millions of people worldwide, yet little data is available to guide treatment strategies for the most common symptoms. We conducted a scoping review of PubMed/Medline from 1/1/2020 –4/1/2023 to identify studies addressing diagnosis and treatment of the most common post-acute neurological sequelae of COVID-19 including: cognitive impairment, sleep disorders, headache, dizziness/lightheadedness, fatigue, weakness, numbness/pain, anxiety, depression and post-traumatic stress di sorder.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Jennifer A. Frontera, Alla Guekht, Ricardo F. Allegri, Mariam Ashraf, Bet ül Baykan, Lucía Crivelli, Ava Easton, David Garcia-Azorin, Raimund Helbok, Jatin Joshi, Julia Koehn, Igor Koralnik, M. Netravathi, Benedict Michael, Annacarmen Nilo, Aynur Özge, Tags: Review Article Source Type: research
More News: Anxiety | Brain | COVID-19 | Depression | Headache | Migraine | Neurology | Pain | Post Traumatic Stress Disorder | Sleep Disorders | Sleep Medicine | Study